ATOSSA THERAPEUTICS, INC. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-106947
- Form type
- 10-Q
- CIK
- 0001488039
- Primary document
- https://www.sec.gov/Archives/edgar/data/1488039/000095017025106947/atos-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ATOSSA THERAPEUTICS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-16.5M | - | - |
| Net Income | $-15.1M | - | - |
| Eps Basic | -0.12 | - | - |
| Eps Diluted | -0.12 | - | - |
| Cash And Equivalents | $57.9M | - | - |
| Total Assets | $64.5M | - | - |
| Total Liabilities | $6.8M | - | - |
| Shareholders Equity | $57.7M | - | - |
| Operating Cash Flow | $-13.2M | - | - |
| Capital Expenditures | $9,000 | - | - |